ANI Pharmaceuticals Inc (ANIP)

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ANI Pharmaceuticals, Inc ... - Longview News-Journal

Longview News-Journal

Gilead (GILD) Announces Positive Interim Results on PBC Drug

Zacks Investment Research

Has Acrivon Therapeutics, Inc. (ACRV) Outpaced Other Medical Stocks This Year?

Zacks Investment Research

Down -6.19% in 4 Weeks, Here's Why ANI (ANIP) Looks Ripe for a Turnaround

Zacks Investment Research

Here's Why Merck (MRK) Stock Has Outperformed Industry YTD

Zacks Investment Research

ANI Pharmaceuticals Announces the Launch of Kionex® Suspension - GlobeNewswire

GlobeNewswire

ANI Pharmaceuticals Announces the Launch of Kionex® Suspension

GlobeNewswire Inc.

Muthusamy Shanmugam Sells 5836 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock - Defense World

Defense World

Renee P. Tannenbaum Sells 2000 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock - Defense World

Defense World

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) COO Muthusamy Shanmugam Sells 14850 Shares - Defense World

Defense World

Insider Selling: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) CEO Sells 16669 Shares of Stock - Defense World

Defense World

Ani Pharmaceuticals director sells $127,740 in company stock By Investing.com - Investing.com Australia

Investing.com Australia

Director Renee Tannenbaum Sells 2,000 Shares of ANI Pharmaceuticals Inc (ANIP) - Yahoo Finance UK

Yahoo Finance UK

Director Renee Tannenbaum Sells 2,000 Shares of ANI Pharmaceuticals Inc (ANIP) - Yahoo Finance

Yahoo Finance

Ani Pharmaceuticals director sells $127,740 in company stock By Investing.com - Investing.com Canada

Investing.com Canada

Ani Pharmaceuticals director sells $127,740 in company stock By Investing.com - Investing.com

Investing.com

Ani Pharmaceuticals executive sells over $2.3 million in company stock - Investing.com Australia

Investing.com Australia

Ani Pharmaceuticals executive sells over $2.3 million in company stock - Investing.com Canada

Investing.com Canada

Ani Pharmaceuticals executive sells over $2.3 million in company stock - Investing.com

Investing.com

Ani Pharmaceuticals director sells $127,740 in company stock By Investing.com - Investing.com UK

Investing.com UK

Here's Why Incyte (INCY) Stock is Up More Than 7% in a Week

Zacks Investment Research

Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control

Zacks Investment Research

J&J (JNJ) to Boost Dermatology Portfolio With New Acquisition

Zacks Investment Research

Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC

Zacks Investment Research

New York State Common Retirement Fund Has $313000 Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - Defense World

Defense World

Renee P. Tannenbaum Sells 2,000 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Stock - MarketBeat

MarketBeat

ANI Pharmaceuticals, Inc. (ANIP) Looks Strong: Stock Soars 20.7% - Yahoo Singapore News

Yahoo Singapore News

Ani Pharmaceuticals CEO sells shares worth over $1.1 million - Investing.com South Africa

Investing.com South Africa

Will ANI Pharmaceuticals (ANIP) Continue to Surge Higher? - Yahoo New Zealand News

Yahoo New Zealand News

Insider Selling: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) CEO Sells 16,669 Shares of Stock - MarketBeat

MarketBeat

Insider Selling: President & CEO Nikhil Lalwani Sells Shares of ANI Pharmaceuticals Inc (ANIP) - Yahoo Finance

Yahoo Finance

Ani Pharmaceuticals CEO sells shares worth over $1.1 million - Investing.com

Investing.com

Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus

Zacks Investment Research

Vanda (VNDA) Rises on Positive Data From Motion Sickness Study

Zacks Investment Research

Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion

Zacks Investment Research

ANI Pharmaceuticals Down 25% After Earnings Miss - Yahoo News UK

Yahoo News UK

FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing

Zacks Investment Research

ANI Pharmaceuticals (ANIP) Stock Sinks As Market Gains: Here's Why - Yahoo Lifestyle Australia

Yahoo Lifestyle Australia

ANI Pharmaceuticals (NASDAQ:ANIP) PT Raised to $87.00 at HC Wainwright - Defense World

Defense World

ANI Pharmaceuticals' (NASDAQ:ANIP) Shareholders Are Down 51% On Their Shares - Yahoo New Zealand News

Yahoo New Zealand News

ANI Pharmaceuticals Financial Health Overview Released - TipRanks.com - TipRanks

TipRanks

Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag

Zacks Investment Research

Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals

Zacks Investment Research

Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility

Zacks Investment Research

Ani Pharmaceuticals executive sells $16.9k in stock - Investing.com India

Investing.com India

ANI Pharmaceuticals shares target raised by H.C. Wainwright on strong Q1 performance - Investing.com India

Investing.com India

Ani Pharmaceuticals executive sells $16.9k in stock By Investing.com - Investing.com

Investing.com

ANI Pharmaceuticals (NASDAQ:ANIP) PT Raised to $87.00 - MarketBeat

MarketBeat

Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag

Zacks Investment Research

ANI Pharmaceuticals shares target raised by H.C. Wainwright on strong Q1 performance - Investing.com

Investing.com